Clinical Trials Directory

Trials / Conditions / Head and Neck Cancer Squamous Cell Carcinoma

Head and Neck Cancer Squamous Cell Carcinoma

12 registered clinical trials studyying Head and Neck Cancer Squamous Cell Carcinoma — 10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPDT For Induction Therapy For Head And Neck Cancer
NCT07214987
Massachusetts General HospitalPhase 2
RecruitingEfficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck
NCT06959082
VSPharmTech Co.,Ltd.Phase 2
RecruitingA Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Nec
NCT07457346
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
RecruitingStereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma
NCT07337161
David PalmaN/A
CompletedOzone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy
NCT07199712
University of PaviaN/A
Not Yet RecruitingImproved Oral Health in Head and Neck Cancer Survivors
NCT07173270
Uppsala UniversityN/A
Not Yet RecruitingNeoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcin
NCT07145931
Sun Yat-sen UniversityPhase 2
RecruitingA Study of SH009 Injection in Patients With Advanced Solid Tumors.
NCT07390838
Nanjing Sanhome Pharmaceutical, Co., Ltd.Phase 1
RecruitingSurufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
NCT06876844
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
RecruitingBone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
NCT06752798
Hunan Cancer HospitalPhase 2
Enrolling By InvitationHypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT06768125
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
TerminatedStudy of ADCT-301 in Patients With Selected Advanced Solid Tumors
NCT03621982
ADC Therapeutics S.A.Phase 1